Claro Advisors LLC Increases Stake in Intuitive Surgical, Inc.

Claro Advisors LLC has significantly raised its investment in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.8% during the third quarter, according to their recent filing with the Securities and Exchange Commission (SEC). After acquiring 495 additional shares during this period, Claro Advisors now holds a total of 1,398 shares in the medical equipment company, valued at approximately $687,000.

Several other institutional investors have also adjusted their holdings in Intuitive Surgical. For instance, Ullmann Wealth Partners Group LLC increased its stake by 1.6% in the third quarter, bringing its total to 1,329 shares worth $653,000 after adding 21 shares. Similarly, One Wealth Management Investment & Advisory Services LLC enhanced its position by 3.4% in the previous quarter, now owning 697 shares valuated at $310,000. Daymark Wealth Partners LLC also grew its share in the company by 0.3%, holding 7,027 shares valued at $3,452,000 after purchasing 24 additional shares. Other notable increases include Indiana Trust & Investment Management CO, which raised its stake by 5.3%, and Hoxton Planning & Management LLC, which boosted its position by 4.9%. Overall, institutional investors and hedge funds own about 83.64% of Intuitive Surgical's stock.

Recent Insider Transactions

In related news, insider Mark Brosius sold 2,115 shares of Intuitive Surgical on September 12th for an average price of $491.91, totaling approximately $1,040,389.65. Post-sale, Brosius retained 295 shares worth around $145,113.45, which shows no change in the percentage of his ownership. In another transaction, EVP Robert Desantis sold 1,413 shares on July 26th for an average price of $438.60, which amounted to $619,741.80. After this sale, he now holds 5,506 shares valued at $2,414,931.60. Over the past three months, insiders have sold a total of 53,120 shares worth $25,528,753, indicating that insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Overview

As of Friday, Intuitive Surgical’s stock was trading at $521.15. The company has experienced a one-year low of $254.85 and a high of $523.34. It maintains a 50-day and 200-day simple moving average of $483.85 and $438.17, respectively, and has a market capitalization of $184.85 billion. The price-to-earnings (P/E) ratio stands at 94.07, with a P/E/G ratio of 5.40, and a beta of 1.39.

Intuitive Surgical recently reported its quarterly earnings on July 18th, where it achieved $1.78 earnings per share, exceeding analysts' expectations of $1.54. The company's revenue for the quarter reached $2.01 billion, surpassing forecasts of $1.97 billion, and representing a 14.5% increase compared to the previous year. Analysts predict that Intuitive Surgical, Inc. will report earnings of 5.22 per share for the current year.

Broker Ratings and Price Targets

Several brokerage firms have issued updates on Intuitive Surgical. Truist Financial raised its price target from $520.00 to $570.00 while maintaining a “buy” recommendation. The Goldman Sachs Group suggested a price target of $604.00, while Raymond James increased their target from $500.00 to $540.00, also rating the stock as “outperform.” Leerink Partners and Royal Bank of Canada made similar adjustments, boosting their price objectives. Currently, one analyst has issued a sell rating, five have a hold rating, and fourteen recommend buying the stock, leading to an average rating of “Moderate Buy” with a consensus price target of $513.74.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products to enhance minimally invasive care globally. Notably, the company offers the da Vinci Surgical System, facilitating complex surgeries through a minimally invasive approach. Additionally, its Ion endoluminal system broadens its offerings to include diagnostic procedures for lung biopsies.

Intuitive, Surgical, Investment